Minimal residual disease defines the risk and time to biochemical failure in patients with Pt2 and Pt3a prostate Cancer treated with radical prostatectomy: an …

NP Murray, S Aedo, C Fuentealba, E Reyes… - Urology …, 2020 - ojs3.sbmu.ac.ir
Purpose: To compare Gleason score (GS), pathological stage, minimal residual disease
(MRD) and outcome after prostatectomy radical for prostate cancer. Patients and Methods …

[引用][C] The ability of systematic TRUS-biopsies to detect clinically significant prostate cancer stratified by age, clinical tumor category and PSA in the Danish population …